Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Stock Tracker

This tool allows subscribers to track the progress of share prices belonging to all of the key listed animal health companies.

Aratana begins developing AT-019 to build on EP4 base

Aratana Therapeutics is progressing R&D work on a candidate that targets the prostaglandin EP4 receptor.

Aratana Therapeutics R&D

Zoetis, Elanco secure FDA approval for poultry products

Zoetis and Elanco have both recently received approval for poultry products in the US.

Product Approvals Pharmaceuticals

Zoetis, Merck and IDEXX stand out in mixed H1 for industry leaders

Halfway through 2018, three of the leading animal health players have made great strides in terms of top-line growth. Others have fallen foul of currency exchange issues. Animal Pharm editor Joseph Harvey looks out how the first six months panned out for the top 10.

Financial Results Operations

Phibro shares up 56% on back of strong 2018 and growth strategies

Phibro Animal Health has recently seen the value of its shares reach a record high.

Phibro Animal Health Markets

Phibro to see financial benefits from companion animal innovation within two years

Phibro Animal Health claims it will see an impact on its bottom line from in-licencing novel companion animal products in the next 18 to 24 months.

Phibro Animal Health R&D

International growth boosts Phibro Q4, end-of-year performance

US firm Phibro Animal Health has recorded a 9% increase in sales in the fourth quarter of its fiscal 2018, backed by international growth.

Phibro Animal Health Financial Results
See All